MITRO Biotech Co., Ltd.

Established in 2012, MITRO Biotech Co., Ltd. focuses on providing professional and efficient CRO and CDMO services of radiolabeling and molecular imaging to the global pharmaceutical and biopharmaceutical industries. Headquartered in Jiangning District, Nanjing City, it currently has offices in China, the United States, and the United Kingdom with around 200 employees worldwide. With Radiolabeling and Molecular Imaging technology, MITRO provides outsourcing technical services such as drug screening, biodistribution, PK study and PD evaluation for pharmaceutical enterprises and research institutes at home and abroad. It also provides one-stop solutions for new drug R&D, including labeling method development, pharmacological studies, non-clinical studies, clinical studies, and registration application. Our business focuses on studies such as oncological, nervous system diseases, autoimmune diseases, cardiovascular and cerebrovascular diseases, as well as innovative therapies such as immunity, gene therapy, and cell therapy, so as to explore disease mechanisms, developing diagnostic and therapeutic drugs, and evaluate therapeutic effects.